Pseudomonas Pneumonia - an overview | ScienceDirect Topics
Pseudomonas pneumonia due to hematogenous spread is characterized by areas of necrosis that are usually surrounded by a red halo of congestion and hemorrhage (Fig. 10.10), which go on to form cavities (Fig. 10.11). Microscopic Findings
Pseudomonas Pneumonia - an overview | ScienceDirect Topics
Pseudomonas pneumonia. The species of Pseudomonas involved in lung infections is usually Pseudomonas aeruginosa, which is the commonest bacterium isolated in hospital-acquired pneumonia. 15 Infection may be inhalational or blood-borne. Infection via the airways generally follows colonisation of the pharynx, especially in patients on antibiotics ...
Pseudomonas Pneumonia - an overview | ScienceDirect Topics
2010年7月2日 · Pseudomonas pneumonia is rare in normal hosts, but it can develop after exposure to aerosols of contaminated water such as in hot tubs. 21,24,40,68,177,178 P. aeruginosa is a leading cause of nosocomial pneumonia and a particularly frequent cause of VAP. 179 Prolonged endotracheal intubation and prior antibiotic therapy, especially with broad ...
Pseudomonas fluorescens pneumonia - ScienceDirect
2024年3月1日 · Although a study by Dickson et al. [4] included some pneumonia cases, they were chronic immunosuppressed or aspiration pneumonia and were not described as having pneumonia alone. In addition, many of these patients were found to have oral flora co-isolated with P. fluorescens , which was different from the present case.
Pneumonia Due to Pseudomonas aeruginosa : Part I: Epidemiology ...
2011年4月1日 · Pseudomonas pneumonia was characterized as a diffuse bronchopneumonia with nodularity and “small areas of radiolucency (‘microabcesses’).” 97 Of note, subsequent pathologic correlates suggested that the microabscesses were actually areas of normal or emphysematous lung surrounded by an infected infiltrated lung, the “air-alveolograms ...
Pneumonia Due to Pseudomonas aeruginosa : Part I: Epidemiology ...
2011年4月1日 · Multidrug-resistance (MDR) Pseudomonas aeruginosa (P. aeruginosa) is a lethal gram-negative pathogen causing hospital-acquired and ventilator-associated pneumonia, which is difficult to treat. Our previous studies confirmed that baicalin, an essential bioactive component in Scutellaria baicalensis Georgi, exhibited anti-inflammatory effects in ...
Pseudomonas aeruginosa: Infections and novel approaches to …
2023年9月1日 · Pneumonia is caused by P. aeruginosa and is divided into four categories: (1) Hospital-acquired pneumonia, which occurs 48 hours or more after hospitalization; (2) Ventilator-associated pneumonia that develops more than 48 to 72 hours after endotracheal intubation; (3) Health care-associated pneumonia occurs among nonhospitalized patients, who ...
Impact of Pseudomonas aeruginosa carriage on ICU-acquired …
2024年11月10日 · Pseudomonas aeruginosa (PA) is a common causative pathogen of pneumonia acquired in the ICU. The aim of this study was to determine the incidence of PA ICU pneumonia (PAIP) and to quantify its independent association with …
The global epidemiology of ventilator-associated pneumonia …
2024年2月1日 · Ventilator-associated pneumonia (VAP) is a nosocomial pneumonia that occurs in patients who are in intensive care unit (ICU) receiving mechanical ventilation [1]. It is one of the most common healthcare-associated infections (HAIs) with an incidence of 55.3% (95% confidence interval [CI], 0.465-0.657) [2].
Pharmacological effects and mechanism of Maxing Shigan …
2024年2月10日 · Thus non-antibiotic therapeutic approaches, which develop new adjuvant drugs that could reduce the severity of MDR P. aeruginosa pneumonia is a sustainable and effective strategy against MDR bacteria. Traditional Chinese Medicine (TCM) is a well-known treatment option for pneumonia (Hsieh et al., 2012; Lin et al., 2019).